About Lexicon Pharmaceuticals
Lexicon Pharmaceuticals is a company based in United States founded in 1995.. Lexicon Pharmaceuticals has raised $165 million across 12 funding rounds from investors including NEA, Bay City Capital and Military Health. The company has 103 employees as of December 31, 2024. Lexicon Pharmaceuticals offers products and services including Gene-based Therapies. Lexicon Pharmaceuticals operates in a competitive market with competitors including Metabolon, Kriya Therapeutics, Sana Biotechnology, Semma Therapeutics and Maze Therapeutics, among others.
- Headquarter United States
- Employees 103 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Lexicon Pharmaceuticals, Inc.
-
Annual Revenue
$31.08 M2481.48as on Dec 31, 2024
-
Net Profit
$-200.4 M-13.15as on Dec 31, 2024
-
EBITDA
$-184.28 M-7.64as on Dec 31, 2024
-
Total Equity Funding
$165 M (USD)
in 12 rounds
-
Latest Funding Round
$42.89 M (USD), Post-IPO
Aug 03, 2022
-
Investors
NEA
& 2 more
-
Employee Count
103
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Lexicon Pharmaceuticals
Lexicon Pharmaceuticals is a publicly listed company on the NASDAQ with ticker symbol LXRX in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Lexicon Pharmaceuticals
Lexicon Pharmaceuticals offers a comprehensive portfolio of products and services, including Gene-based Therapies. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Develops medicines targeting neuropathic pain and cardiometabolic disorders using gene science.
Unlock access to complete
Leadership Team
10 people
Product Management Team
6 people
Legal and Compliance
4 people
Human Resources and Administration
4 people
Software Development Team
3 people
Operations Team
3 people
Clinical Team
2 people
Finance and Accounting
2 people
Unlock access to complete
Funding Insights of Lexicon Pharmaceuticals
Lexicon Pharmaceuticals has successfully raised a total of $165M across 12 strategic funding rounds. The most recent funding activity was a Post-IPO round of $42.89 million completed in August 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 12
- Last Round Post-IPO — $42.9M
- First Round First Round
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2022 | Amount | Post-IPO - Lexicon Pharmaceuticals | Valuation |
investors |
|
| Mar, 2017 | Amount | Post-IPO - Lexicon Pharmaceuticals | Valuation |
investors |
|
| Dec, 2014 | Amount | Post-IPO - Lexicon Pharmaceuticals | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Lexicon Pharmaceuticals
Lexicon Pharmaceuticals has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include NEA, Bay City Capital and Military Health. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investments are offered to startups by NEA.
|
Founded Year | Domain | Location | |
|
Stage-agnostic investments in US life-sciences sectors are managed.
|
Founded Year | Domain | Location | |
|
Administers health care and support for military personnel and operations.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Lexicon Pharmaceuticals
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Lexicon Pharmaceuticals
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Lexicon Pharmaceuticals Comparisons
Competitors of Lexicon Pharmaceuticals
Lexicon Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Metabolon, Kriya Therapeutics, Sana Biotechnology, Semma Therapeutics and Maze Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Solutions for biomarker discovery and diagnostic testing are provided.
|
|
| domain | founded_year | HQ Location |
Developer of therapeutic solutions for the treatment of diabetes
|
|
| domain | founded_year | HQ Location |
Genetically engineered cell therapies are developed for multiple disorders.
|
|
| domain | founded_year | HQ Location |
Provider of bio-artificial pancreas for Type 1 Diabetes treatment
|
|
| domain | founded_year | HQ Location |
Genetic biomarkers are developed for neurological, metabolic, and renal diseases.
|
|
| domain | founded_year | HQ Location |
Therapeutics for diabetes and obesity treatment are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Lexicon Pharmaceuticals
Frequently Asked Questions about Lexicon Pharmaceuticals
When was Lexicon Pharmaceuticals founded?
Lexicon Pharmaceuticals was founded in 1995 and raised its 1st funding round 3 years after it was founded.
Where is Lexicon Pharmaceuticals located?
Lexicon Pharmaceuticals is headquartered in United States.
Is Lexicon Pharmaceuticals a funded company?
Lexicon Pharmaceuticals is a funded company, having raised a total of $165M across 12 funding rounds to date. The company's 1st funding round was a Post-IPO of $4.66M, raised on May 01, 1998.
How many employees does Lexicon Pharmaceuticals have?
As of Dec 31, 2024, the latest employee count at Lexicon Pharmaceuticals is 103.
What is the annual revenue of Lexicon Pharmaceuticals?
Annual revenue of Lexicon Pharmaceuticals is $31.08M as on Dec 31, 2024.
What does Lexicon Pharmaceuticals do?
Lexicon Pharmaceuticals was founded in 1995 in the United States as a biopharmaceutical company. Gene trapping and targeting technologies are utilized to identify drug targets and create small molecule drugs. Focus areas include oncology, gastroenterology, immunology, metabolism, and ophthalmology. Operations center on research and development within the healthcare sector, with activities based primarily in the U.S.
Who are the top competitors of Lexicon Pharmaceuticals?
Lexicon Pharmaceuticals's top competitors include Maze Therapeutics, Metabolon and Sana Biotechnology.
What products or services does Lexicon Pharmaceuticals offer?
Lexicon Pharmaceuticals offers Gene-based Therapies.
Is Lexicon Pharmaceuticals publicly traded?
Yes, Lexicon Pharmaceuticals is publicly traded on NASDAQ under the ticker symbol LXRX.
Who are Lexicon Pharmaceuticals's investors?
Lexicon Pharmaceuticals has 3 investors. Key investors include NEA, Bay City Capital, and Military Health.
What is Lexicon Pharmaceuticals's ticker symbol?
The ticker symbol of Lexicon Pharmaceuticals is LXRX on NASDAQ.